The Government of Alberta has made Pluvicto, a new radiopharmaceutical treatment for advanced prostate cancer, available to Albertans in an effort to improve treatment access.

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Pope Francis is eating and intravenous feeding has never been mentioned, the Vatican said as he continues to battle pneumonia ...

Hyperemesis gravidarum affects 3% of pregnancies, causing severe vomiting and dehydration. Experts explain the causes, ...

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

In a bid to circumvent ongoing global supply chain issues of vital intravenous fluids, the Albanese government has announced they will invest $20 million to ramp up local manufacturing. Please login ...

The following is a summary of “Discarded intravenous medication in the ICU: the GAME-OVER multicenter prospective observational study,” published in the February 2025 issue of Critical Care by ...

One afternoon in 2022, when it became clear that the Tennessee Department of Correction had violated or otherwise ignored ...

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...